Jennifer M. Zerbato

1.0k total citations
25 papers, 662 citations indexed

About

Jennifer M. Zerbato is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jennifer M. Zerbato has authored 25 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Virology, 13 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in Jennifer M. Zerbato's work include HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (10 papers) and HIV/AIDS Research and Interventions (7 papers). Jennifer M. Zerbato is often cited by papers focused on HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (10 papers) and HIV/AIDS Research and Interventions (7 papers). Jennifer M. Zerbato collaborates with scholars based in Australia, United States and Thailand. Jennifer M. Zerbato's co-authors include Nicolas Sluis‐Cremer, John W. Mellors, Sharon R. Lewin, Geneviève Doyon, Thomas A. Rasmussen, Ashanti Dantanarayana, Deborah K. McMahon, Wei Zhao, James McMahon and Stephen H. Hughes and has published in prestigious journals such as Nature Medicine, Nature Communications and The Journal of Immunology.

In The Last Decade

Jennifer M. Zerbato

22 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer M. Zerbato Australia	15	495	321	266	150	143	25	662
Alyssa R. Martin United States	7	774 1.6×	481 1.5×	323 1.2×	211 1.4×	155 1.1×	14	889
Carolina Garrido United States	13	554 1.1×	289 0.9×	355 1.3×	157 1.0×	213 1.5×	20	770
Caitlyn Linde United States	11	384 0.8×	197 0.6×	413 1.6×	193 1.3×	138 1.0×	13	662
Evelyn E. Eisele United States	6	762 1.5×	464 1.4×	306 1.2×	162 1.1×	145 1.0×	6	864
Katherine Perkey United States	7	698 1.4×	452 1.4×	290 1.1×	80 0.5×	169 1.2×	9	857
Wendy Bakeman United States	6	625 1.3×	359 1.1×	325 1.2×	108 0.7×	153 1.1×	7	753
Josephine Romano United States	10	466 0.9×	221 0.7×	269 1.0×	109 0.7×	99 0.7×	12	526
Elizabeth Fyne United States	7	444 0.9×	324 1.0×	152 0.6×	124 0.8×	82 0.6×	8	532
Jason J. Coull United States	7	395 0.8×	373 1.2×	134 0.5×	192 1.3×	122 0.9×	9	603
Julie Sullivan United States	11	665 1.3×	401 1.2×	338 1.3×	109 0.7×	133 0.9×	13	795

Countries citing papers authored by Jennifer M. Zerbato

Since Specialization

Citations

This map shows the geographic impact of Jennifer M. Zerbato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer M. Zerbato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer M. Zerbato more than expected).

Fields of papers citing papers by Jennifer M. Zerbato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer M. Zerbato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer M. Zerbato. The network helps show where Jennifer M. Zerbato may publish in the future.

Co-authorship network of co-authors of Jennifer M. Zerbato

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer M. Zerbato. A scholar is included among the top collaborators of Jennifer M. Zerbato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer M. Zerbato. Jennifer M. Zerbato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eagle, Shawn R., Jason Barber, Nancy Temkin, et al.. (2025). Follow up rates and patient interest in clinical care after mild traumatic brain injury presenting to a level 1 trauma center: a TRACK-TBI prospective cohort study. Frontiers in Neurology. 16. 1558204–1558204. 1 indexed citations

Zhao, Wei, Kasha P. Singh, Fernando J. Rossello, et al.. (2025). Hepatitis B surface antigen is upregulated by HIV Tat in an HIV–hepatitis B virus co-infection model system. Microbiology Spectrum. 13(9). e0080925–e0080925.

Singh, Kasha P., Anchalee Avihingsanon, Jennifer M. Zerbato, et al.. (2024). Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy. EBioMedicine. 102. 105054–105054. 3 indexed citations

Zerbato, Jennifer M., Anchalee Avihingsanon, Timothy E. Schlub, et al.. (2022). Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals. Journal of Virology. 96(16). e0058822–e0058822. 5 indexed citations

Zerbato, Jennifer M., Anchalee Avihingsanon, Kasha P. Singh, et al.. (2022). HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy. EBioMedicine. 87. 104391–104391. 18 indexed citations

Zerbato, Jennifer M., Ajantha Rhodes, Chris Chiu, et al.. (2022). Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR). Pathology. 54(5). 623–628.

Fareh, Mohamed, Wei Zhao, Wenxin Hu, et al.. (2021). Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance. Nature Communications. 12(1). 4270–4270. 48 indexed citations

Zerbato, Jennifer M., Georges Khoury, Wei Zhao, et al.. (2021). Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency. EBioMedicine. 65. 103241–103241. 25 indexed citations

Coffin, John M., Michael J. Bale, Shuang Guo, et al.. (2021). Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy. PLoS Pathogens. 17(4). e1009141–e1009141. 36 indexed citations

10.

Lau, Jillian S. Y., James McMahon, Ajantha Solomon, et al.. (2021). The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy. AIDS. 35(10). 1631–1636. 24 indexed citations

11.

Singh, Kasha P., Jennifer M. Zerbato, Wei Zhao, et al.. (2020). Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection. PLoS Pathogens. 16(9). e1008744–e1008744. 27 indexed citations

12.

Sluis, Renée M. van der, Nitasha Kumar, Jennifer M. Zerbato, et al.. (2020). Combination Immune Checkpoint Blockade to Reverse HIV Latency. The Journal of Immunology. 204(5). 1242–1254. 41 indexed citations

13.

Sluis, Renée M. van der, Jennifer M. Zerbato, Jake W. Rhodes, et al.. (2020). Diverse effects of interferon alpha on the establishment and reversal of HIV latency. PLoS Pathogens. 16(2). e1008151–e1008151. 37 indexed citations

14.

Coffin, John M., David W. Wells, Jennifer M. Zerbato, et al.. (2019). Clones of infected cells arise early in HIV-infected individuals. JCI Insight. 4(12). 57 indexed citations

15.

Zerbato, Jennifer M., et al.. (2019). Naive CD4+ T Cells Harbor a Large Inducible Reservoir of Latent, Replication-competent Human Immunodeficiency Virus Type 1. Clinical Infectious Diseases. 69(11). 1919–1925. 57 indexed citations

16.

Zerbato, Jennifer M., et al.. (2019). Between a shock and a hard place: challenges and developments in HIV latency reversal. Current Opinion in Virology. 38. 1–9. 51 indexed citations

17.

Sanyal, Anwesha, Robbie B. Mailliard, Charles R. Rinaldo, et al.. (2017). Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4+ T cells. Nature Medicine. 23(7). 885–889. 58 indexed citations

18.

Zerbato, Jennifer M., Gilda Tachedjian, & Nicolas Sluis‐Cremer. (2016). Nonnucleoside Reverse Transcriptase Inhibitors Reduce HIV-1 Production from Latently Infected Resting CD4 ⁺ T Cells following Latency Reversal. Antimicrobial Agents and Chemotherapy. 61(3). 9 indexed citations

19.

Doyon, Geneviève, Jennifer M. Zerbato, John W. Mellors, & Nicolas Sluis‐Cremer. (2012). Disulfiram reactivates latent HIV-1 expression through depletion of the phosphatase and tensin homolog. AIDS. 27(2). F7–F11. 86 indexed citations

20.

Dunnick, Wesley A., et al.. (2011). Enhancement of Antibody Class-Switch Recombination by the Cumulative Activity of Four Separate Elements. The Journal of Immunology. 187(9). 4733–4743. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact